Canada markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.28+0.11 (+1.08%)
At close: 04:00PM EDT
10.00 -0.28 (-2.72%)
After hours: 07:44PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.04B
Enterprise Value 3.20B
Trailing P/E N/A
Forward P/E 72.99
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)7.60
Price/Book (mrq)19.01
Enterprise Value/Revenue 8.02
Enterprise Value/EBITDA -34.79

Trading Information

Stock Price History

Beta (5Y Monthly) 0.76
52-Week Change 3-13.61%
S&P500 52-Week Change 322.36%
52 Week High 314.57
52 Week Low 39.70
50-Day Moving Average 311.92
200-Day Moving Average 312.21

Share Statistics

Avg Vol (3 month) 33.05M
Avg Vol (10 day) 33M
Shares Outstanding 5296.18M
Implied Shares Outstanding 6295.38M
Float 8222.32M
% Held by Insiders 10.72%
% Held by Institutions 1109.63%
Shares Short (Apr 15, 2024) 431.32M
Short Ratio (Apr 15, 2024) 412.13
Short % of Float (Apr 15, 2024) 410.65%
Short % of Shares Outstanding (Apr 15, 2024) 410.60%
Shares Short (prior month Mar 15, 2024) 432.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -37.96%
Operating Margin (ttm)-3.21%

Management Effectiveness

Return on Assets (ttm)-6.12%
Return on Equity (ttm)-107.04%

Income Statement

Revenue (ttm)399.36M
Revenue Per Share (ttm)1.35
Quarterly Revenue Growth (yoy)30.60%
Gross Profit (ttm)N/A
EBITDA -65.62M
Net Income Avi to Common (ttm)-151.58M
Diluted EPS (ttm)-0.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)286.2M
Total Cash Per Share (mrq)0.97
Total Debt (mrq)445.06M
Total Debt/Equity (mrq)277.86%
Current Ratio (mrq)2.88
Book Value Per Share (mrq)0.55

Cash Flow Statement

Operating Cash Flow (ttm)-69.09M
Levered Free Cash Flow (ttm)-25.89M